Smart and low-cost fluorometer for identifying breast cancer malignancy based on lipid droplets accumulation

PLoS One. 2023 Dec 21;18(12):e0294988. doi: 10.1371/journal.pone.0294988. eCollection 2023.

Abstract

The most common cause of breast cancer-related death is tumor recurrence. To develop more effective treatments, the identification of cancer cell specific malignancy indicators is therefore critical. Lipid droplets are known as an emerging hallmark in aggressive breast tumors. A common technique that can be used for observing molecules in cancer microenvironment is fluorescence microscopy. We describe the design, development and applicability of a smart fluorometer to detect lipid droplet accumulation based on the emitted fluorescence signals from highly malignant (MDA-MB-231) and mildly malignant (MCF7) breast cancer cell lines, that are stained with BODIPY dye. This device uses a visible-range light source as an excitation source and a spectral sensor as the detector. A commercial imaging system was used to examine the fluorescent cancer cell lines before being validated in a preclinical setting with the developed prototype. The outcomes indicate that this low-cost fluorometer can effectively detect the alterations levels of lipid droplets and hence distinguish between "moderately malignant" and "highly malignant" cancer cells. In comparison to prior research that used fluorescence spectroscopy techniques to detect cancer biomarkers, this study revealed enhanced capability in classifying mildly and highly malignant cancer cell lines.

MeSH terms

  • Breast / pathology
  • Breast Neoplasms* / pathology
  • Female
  • Humans
  • Lipid Droplets / metabolism
  • Microscopy, Fluorescence
  • Neoplasm Recurrence, Local / pathology
  • Tumor Microenvironment

Grants and funding

The New Frontiers in Research Fund (NFRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.